Long-term outcomes of endovascular therapy for right subclavian artery occlusive lesions: A multi-center experience
Vascular · 2025
DOI: 10.1177/17085381241247613 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Vascular, 2025. Verfasst von Yulong Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Xiamen Branch of Zhongshan Hospital, Fudan University, Xiamen, China. Hauptthemen laut MEDLINE: Subclavian Artery, Angioplasty, Balloon, Subclavian Steal Syndrome, Arterial Occlusive Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Xiamen Medical and Health Guidance Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To review our multi-institutional experience with endovascular therapy for right subclavian artery occlusive disease and to evaluate the long-term outcomes.
Methods
We retrospectively evaluated all patients with right subclavian artery stenosis and occlusive disease who underwent endovascular therapy between March 2014 and September 2022 at two institutions. Patient baseline demographics, lesion characteristics, treatment strategies, and in-hospital and follow-up outcomes were prospectively collected and retrospectively analyzed.
Results
Between March 2014 and September 2022, 73 patients underwent endovascular treatment at the two institutions. The dominant cause of lesions in this cohort was atherosclerosis. Three different types of lesions were summarized, and the corresponding endovascular strategies were performed. 66 patients (90.4%) underwent successful endovascular treatment, and 62 patients (84.9%) underwent balloon-expandable stent deployment. The mean perioperative in-hospital stay was 4.0 days (range, 3–6 days). Two patients died due to myocardial infarction, and one died of cerebral hemorrhage resulting from a traffic accident within 30 days of the intervention. The median follow-up time was 31.6 months (range, 12–96 months). No complications, including death, stroke, stent fractures, or migration, were noted in any patient during the follow-up period. The overall complication rate was 7/73 (9.6%), and 5/7 (6.9%) of the complications required reintervention.
Conclusions
Endovascular treatment of right subclavian artery lesions is safe, effective, and technically achievable. The reasonable use of balloon-expandable stents can achieve satisfactory outcomes with accurate orientation and promising patency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Xiamen Branch of Zhongshan Hospital, Fudan University, Xiamen, China.
- Department of Radiology, Xiamen Branch of Zhongshan Hospital, Fudan University, Xiamen, China.
- Department of Vascular Surgery, Fudan University, Shanghai, China.
- Institute of Vascular Surgery, Fudan University, Shanghai, China.
ORCID-Profile: Lixin Wang
Förderung
- Xiamen Medical and Health Guidance Project
- National Natural Science Foundation of China
Zitieren
APA
Huang, Y., Xie, X., Huang, G., Lu, W., Hong, S., Chen, Y., Lin, Y., Fu, W., Hong, X., & Wang, L. (2025). Long-term outcomes of endovascular therapy for right subclavian artery occlusive lesions: A multi-center experience. Vascular. https://doi.org/10.1177/17085381241247613
Vancouver
Huang Y, Xie X, Huang G, Lu W, Hong S, Chen Y, et al. Long-term outcomes of endovascular therapy for right subclavian artery occlusive lesions: A multi-center experience. Vascular. 2025. doi:10.1177/17085381241247613
BibTeX
@article{Huang2025,
author = {Huang, Yulong and Xie, Xinsheng and Huang, Guoqiang and Lu, Weifeng and Hong, Shichai and Chen, Yihui and Lin, Yue and Fu, Weiguo and Hong, Xiang and Wang, Lixin},
title = {Long-term outcomes of endovascular therapy for right subclavian artery occlusive lesions: A multi-center experience},
journal = {Vascular},
year = {2025},
doi = {10.1177/17085381241247613}
}
EUVIMED